Latest News

July 24, 2014
What: In 2006, more than 6,500 specialists in transplant medicine worldwide gathered for the first time in one location at the World Transplant Congress (WTC) in Boston. Eight years later, the WTC is convening again, this time in San Francisco.
July 24, 2014
The National Science Foundation (NSF) has tapped UCSF as the lead institution in a new Industry/University Cooperative Research Center (I/UCRC).
July 24, 2014
Researchers at UCSF have discovered that endostatin, a protein that once aroused intense interest as a possible cancer treatment, plays a key role in the stable functioning of the nervous system.
July 17, 2014
New research from UC San Francisco found that 60 percent of the city’s homeless and unstably housed women who are HIV-infected or at high risk to become infected have endured a recent experience of some form of violence.
July 17, 2014
Sam Hawgood has been confirmed as UCSF’s 10th chancellor in a unanimous vote by the UC Board of Regents. In his acceptance speech, he outlined his vision for the University.
July 15, 2014
UCSF Medical Center is among the nation's premier hospitals for the 13th consecutive year, ranking as the eighth best hospital in the country according to U.S. News & World Report.
July 15, 2014
A brain region that is vital for memory and shrinks in Alzheimer’s disease patients also is likely to be smaller in those whose white blood cells have shorter DNA-protecting end caps – called telomeres – according to a study by Stanford and UCSF researchers.
July 11, 2014
New research from UC San Francisco shows that an “expressive therapy” group intervention conducted by The Medea Project helps women living with HIV disclose their health status and improves their social support, self-efficacy and the safety and quality of their relationships.
July 10, 2014
Twitter and other social media should be better utilized to convey public health messages, especially to young adults, according to a new analysis by researchers at UC San Francisco.
July 10, 2014
In a new study led by UCSF scientists, a chemical compound designed to precisely target part of a crucial cellular quality-control network provided significant protection, in rats and mice, against degenerative forms of blindness and diabetes.

Pages